| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 research v0.36 | NCF4 |
Ellen McDonagh gene: NCF4 was added gene: NCF4 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,GOSH PID v.8.0,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: NCF4 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: NCF4 were set to 29969437; 19692703 Phenotypes for gene: NCF4 were set to Infections, autoinflammatory phenotype; Congenital defects of phagocyte number or function; ?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III 613960; Chronic granulomatous disease (CGD); Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||